Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy.
Syversen SW, Jyssum I, Tveter AT, Sexton J, Christensen IE, Tran TT, Bjørlykke KH, Mjaaland S, Warren DJ, Kvien TK, Chopra A, Kro GB, Jahnsen J, Munthe LA, Haavardsholm EA, Grødeland G, Vaage JT, Provan SA, Jørgensen KK, Goll GL.
Syversen SW, et al. Among authors: munthe la.
RMD Open. 2022 Nov;8(2):e002417. doi: 10.1136/rmdopen-2022-002417.
RMD Open. 2022.
PMID: 36328399
Free PMC article.